REPL stock results show that Replimune Group beat analyst estimates for earnings per share the first quarter of 2025. More
Articles
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
DTEGY Stock Earnings: Deutsche Telekom Reported Results for Q2 2024
Deutsche Telekom just reported results for the second quarter of 2024. More
VRDN Stock Earnings: Viridian Therapeutics Misses EPS, Misses Revenue for Q2 2024
VRDN stock results show that Viridian Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
FEMY Stock Earnings: Femasys Misses EPS, Misses Revenue for Q2 2024
FEMY stock results show that Femasys missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
TNC Stock Earnings: Tennant Beats EPS, Beats Revenue for Q2 2024
TNC stock results show that Tennant beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
EDR Stock Earnings: Endeavor Gr Hldgs Misses EPS, Misses Revenue for Q2 2024
EDR stock results show that Endeavor Gr Hldgs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
